Deltec Partners with Amphastar-IMS.

Business Editors & Health/Medical Writers

ST. PAUL, Minn.--(BUSINESS WIRE)--Aug. 15, 2001

Deltec, Inc. announced today that it has entered into a co-marketing agreement with Amphastar-IMS to promote IMS pre-filled syringes to hospitals for use in their acute pain management programs. The combination of reliable CADD(R) ambulatory PCA pumps and convenient IMS pre-filled syringes will provide Deltec customers with an ambulatory PCA pump alternative to pole-mounted PCA syringe drivers.

With the IMS pre-filled syringes, hospital pain management programs will now have more reservoir options (pre-filled syringes, IV bags, and medication cassettes) for ambulatory PCA delivery, enabling them to increase utilization of ambulatory pumps for both IV PCA and epidural pain management.

"The co-marketing agreement with IMS expands the products Deltec offers its post-op pain management customers, complimenting our new CADD-Prizm(R) PCS II pump and new CADD-DIPLOMAT(R) PC Communications System with Batch Programming," stated Jim Stitt, President of Deltec.

IMS improved the manufacturing process of their pre-filled syringes to reduce stiction inherent in pre-filled syringes and to achieve compatibility with Deltec(R) pumps. The improvement results in accurate and consistent drug delivery when used with any CADD(R) ambulatory PCA pumps.

Dr. Jack Zhang, President and CEO of Amphastar-IMS, commented, "The improvement to the pre-filled syringe manufacturing process and our co-marketing relationship with Deltec fits our strategy of matching our products with the proper delivery system, providing a quality product designed for both patient and clinician."

Deltec, the manufacturer of CADD(R) ambulatory infusion pumps and PORT-A-CATH(R) implantable access systems, is committed to developing the highest quality, most reliable products to provide innovative, convenient and cost-effective drug delivery worldwide. Headquartered in St. Paul, MN, Deltec is part of Smiths Group plc, London and manufactures a wide range of infusion and access systems for domestic and international markets. For additional information, visit Deltec's web site at www.deltec.com.

Since the 1960's, International Medication Systems, Limited (IMS) has developed and manufactured sterile injectable pharmaceuticals to be used in a wide variety of delivery systems, including pre-filled syringes and vial dosage forms for domestic and international markets. Amphastar Pharmaceuticals Inc. was established in February of 1996 by a group of innovative Ph.D. scientists and entrepreneurs. In 1998, Amphastar acquired IMS from Medeva PLC, a London-based international pharmaceutical company. For additional information, visit their web site at www.ims-limited.com.